Sangamo Therapeutics Inc (SGMO) Insider Trading
- $45,174,920.90
- $83,310,269.06
- Sept. 26, 2023
- Ra Capital Management, Llc
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 26, 2023 | Major Shareholder | 6,000,000 | $0.50 | Sell | $3,000,000.00 | |
| Aug. 29, 2022 | Major Shareholder | 400,000 | $5.33 | Sell | $2,132,000.00 | |
| June 3, 2022 | Director | 6,784 | $3.69 | Buy | $25,032.96 | |
| Dec. 27, 2021 | Major Shareholder | 600 | $8.56 | Sell | $5,136.00 | |
| Dec. 23, 2021 | Major Shareholder | 81,187 | $8.55 | Sell | $694,148.85 | |
| Dec. 9, 2021 | Major Shareholder | 23,660 | $8.56 | Sell | $202,529.60 | |
| Dec. 7, 2021 | Major Shareholder | 52,178 | $8.52 | Sell | $444,556.56 | |
| Nov. 26, 2021 | Major Shareholder | 28,884 | $8.60 | Sell | $248,402.40 | |
| March 23, 2021 | EVP | 17,524 | $13.13 | Sell | $230,090.12 | |
| Dec. 24, 2020 | EVP | 3,331 | $18.13 | Sell | $60,391.03 | |
| Dec. 17, 2020 | Director | 10,000 | $13.27 | Sell | $132,700.00 | |
| March 18, 2020 | Director | 3,000 | $5.20 | Buy | $15,600.00 | |
| March 16, 2020 | Director | 15,000 | $6.02 | Sell | $90,300.00 | |
| March 12, 2020 | Director | 15,000 | $6.31 | Buy | $94,650.00 | |
| May 15, 2019 | CFO | 5,000 | $10.00 | Sell | $50,000.00 | |
| April 15, 2019 | CFO | 5,000 | $12.11 | Sell | $60,550.00 | |
| March 15, 2019 | CFO | 5,000 | $10.00 | Sell | $50,000.00 | |
| March 1, 2019 | CFO | 5,000 | $10.00 | Sell | $50,000.00 | |
| Jan. 15, 2019 | CFO | 5,000 | $11.04 | Sell | $55,200.00 | |
| Jan. 7, 2019 | VP | 5,000 | $12.33 | Sell | $61,650.00 | |
| Dec. 17, 2018 | CFO | 5,000 | $11.44 | Sell | $57,200.00 | |
| Dec. 6, 2018 | VP | 5,000 | $11.49 | Sell | $57,450.00 | |
| Nov. 15, 2018 | CFO | 5,000 | $10.00 | Sell | $50,000.00 | |
| Nov. 14, 2018 | Director | 2,000 | $9.00 | Buy | $18,000.00 | |
| Nov. 6, 2018 | VP | 5,000 | $13.73 | Sell | $68,650.00 | |
| Oct. 15, 2018 | CFO | 5,000 | $13.97 | Sell | $69,850.00 | |
| Oct. 8, 2018 | VP | 5,000 | $14.55 | Sell | $72,750.00 | |
| Sept. 17, 2018 | CFO | 5,000 | $14.66 | Sell | $73,300.00 | |
| Sept. 7, 2018 | Director | 2,000 | $13.52 | Buy | $27,040.00 | |
| Sept. 6, 2018 | VP | 5,000 | $14.17 | Sell | $70,850.00 | |
| Aug. 16, 2018 | CFO | 5,000 | $15.39 | Sell | $76,950.00 | |
| Aug. 6, 2018 | VP | 5,000 | $13.45 | Sell | $67,250.00 | |
| July 16, 2018 | CFO | 5,000 | $14.77 | Sell | $73,850.00 | |
| July 6, 2018 | VP | 5,000 | $15.80 | Sell | $79,000.00 | |
| June 15, 2018 | CFO | 5,000 | $15.67 | Sell | $78,350.00 | |
| June 6, 2018 | VP | 5,000 | $16.67 | Sell | $83,350.00 | |
| May 15, 2018 | CFO | 5,000 | $15.38 | Sell | $76,900.00 | |
| May 7, 2018 | VP | 5,000 | $16.36 | Sell | $81,800.00 | |
| April 16, 2018 | CFO | 5,000 | $19.83 | Sell | $99,150.00 | |
| April 13, 2018 | VP | 8,163 | $20.00 | Sell | $163,260.00 | |
| April 6, 2018 | VP | 5,000 | $17.41 | Sell | $87,050.00 | |
| April 2, 2018 | VP | 2,278 | $18.30 | Sell | $41,687.40 | |
| April 2, 2018 | Director | 7,215 | $18.40 | Sell | $132,756.00 | |
| March 15, 2018 | CFO | 5,000 | $25.56 | Sell | $127,800.00 | |
| March 6, 2018 | VP | 5,000 | $24.78 | Sell | $123,900.00 | |
| March 1, 2018 | Director | 9,433 | $23.27 | Sell | $219,505.91 | |
| March 1, 2018 | VP | 15,000 | $23.06 | Sell | $345,900.00 | |
| Feb. 26, 2018 | Director | 9,450 | $24.88 | Sell | $235,116.00 | |
| Feb. 6, 2018 | VP | 5,000 | $18.49 | Sell | $92,450.00 | |
| Feb. 1, 2018 | Director | 11,520 | $20.59 | Sell | $237,196.80 |
Insiders are both buying and selling Sangamo Therapeutics Inc stock.
The insider traders at Sangamo Therapeutics Inc are: Ra Capital Management, Llc, Henry Ward Wolff, Kathy Yi, Philip D Gregory, Edward R. Conner, Dale G Ando, Edward O Lanphier II, Curt A Herberts III, John William Larson, William R Ringo, Edward Lanphier II, Biogen Inc., Saira Ramasastry, Dale Ando, Philip Gregory, H Stewart Parker, Curt A. Herberts III, Steven J Mento, Paul B Cleveland, Joseph S. Zakrzewski, Steven Mento, Rolf Andrew Ramelmeier, Gary Loeb, Stephen George Dilly, John Markels, Edward R Conner, and Paul Cleveland
The most active insider trader at Sangamo Therapeutics Inc is Ra Capital Management, Llc with 67 trades.
Ra Capital Management, Llc has sold the most Sangamo Therapeutics Inc stock with a total value of $51,828,744.34.
Ra Capital Management, Llc has bought the most Sangamo Therapeutics Inc stock with a total value of $45,450,853.84.
The most recent insider trade for Sangamo Therapeutics Inc was on Sept. 26, 2023.
The single biggest insider buy for Sangamo Therapeutics Inc was from Ra Capital Management, Llc with a total value of $5,748,888.25 on March 7, 2015.
The single biggest insider sell for Sangamo Therapeutics Inc was from Ra Capital Management, Llc with a total value of $5,241,865.00 on April 22, 2015.